Babaran, Baby Boy .

HRN: 26-97-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
AMPICILLIN 250MG (VIAL)
05/14/2025
05/20/2025
IV
138mg
Q12
T/C Neonatal Pneumonia
Waiting Final Action 
05/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/14/2025
05/20/2025
IV
41mg
Q24
T/C Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: